Comparison - PHAR - NASDAQ

Weiss Ratings	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Excellent
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.76

Price History	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-10.56%
30-Day Total Return	-7.28%
60-Day Total Return	-20.12%
90-Day Total Return	4.69%
Year to Date Total Return	-24.47%
1-Year Total Return	-26.58%
2-Year Total Return	-38.14%
3-Year Total Return	-12.22%
5-Year Total Return	--
52-Week High % Change	-23.69%
52-Week Low % Change	29.67%

Price	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$11.30
52-Week Low Price	$6.65
52-Week Low Price (Date)	Jul 29, 2024
52-Week High Price (Date)	Apr 11, 2024

Valuation	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	548.91M
Enterprise Value	490.88M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	0.00
Earnings Per Share Growth	-95.02%
Price/Earnings To Growth	--
Price/Sales (TTM)	26.77
Price/Book (Q)	26.48
Enterprise Value/Revenue (TTM)	2.21
Price	$7.90
Enterprise Value/EBITDA (TTM)	-119.73
Enterprise Value/EBIT	-29.74
Market Cap Category	Small Cap

Dividends and Shares	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	688.98M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	31 71 524 7400
Address	--
Website	www.pharming.com
Country	Netherlands
Year Founded	1988

Profitability	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	--
Profit Margin	--

Management Effectiveness	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	--
Return on Equity	--

Income Statement	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	--
Total Revenue (TTM)	--
Revenue Per Share	$0.32
Gross Profit (TTM)	--
EBITDA (TTM)	--
EBIT (TTM)	--
Net Income (TTM)	--
Net Income Avl. to Common (TTM)	--
Total Revenue Growth (Q YOY)	34.97%
Earnings Growth (Q YOY)	-192.34%
EPS Diluted (TTM)	--
EPS Diluted Growth (Q YOY)	-220.00%

Balance Sheet	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	160.32M
Cash Per Share (Q)	$0.23
Total Current Assets (Q)	270.63M
Total Preferred Equity (Q)	--
Total Equity (Q)	220.94M
Current Ratio (Q)	3.386
Book Value Per Share (Q)	$0.33
Total Assets (Q)	415.93M
Total Current Liabilities (Q)	79.94M
Total Debt (Q)	122.02M
Total Liabilities (Q)	194.99M
Total Common Equity (Q)	220.94M

Cash Flow	PHAR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	--
Cash from Financing (TTM)	--
Net Change in Cash (TTM)	--
Levered Free Cash Flow (TTM)	--
Cash from Operations (TTM)	--